What is Wedbush’s Estimate for NHI FY2024 Earnings?

National Health Investors, Inc. (NYSE:NHI) – Wedbush reduced their FY2024 earnings per share (EPS) estimates for National Health Investors in a research note issued on Wednesday, November 6th. Wedbush analyst R. Anderson now forecasts that the real estate investment trust will post earnings of $4.40 per share for the year, down from their prior estimate of $4.52. The consensus estimate for National Health Investors’ current full-year earnings is $4.42 per share. Wedbush also issued estimates for National Health Investors’ Q4 2024 earnings at $1.10 EPS, Q1 2025 earnings at $1.11 EPS, Q2 2025 earnings at $1.15 EPS, Q3 2025 earnings at $1.16 EPS and Q4 2025 earnings at $1.17 EPS.

National Health Investors (NYSE:NHI) last posted its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.42). The business had revenue of $63.32 million for the quarter, compared to analysts’ expectations of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. National Health Investors’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.08 EPS.

A number of other equities research analysts have also recently weighed in on the company. Wells Fargo & Company cut National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price objective for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Bank of America started coverage on National Health Investors in a research note on Tuesday, September 24th. They set a “buy” rating and a $92.00 price target for the company. Truist Financial upped their price target on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, August 30th. Finally, StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, National Health Investors has an average rating of “Moderate Buy” and an average target price of $73.29.

National Health Investors Price Performance

Shares of NYSE NHI opened at $80.26 on Monday. The company has a current ratio of 10.29, a quick ratio of 10.27 and a debt-to-equity ratio of 0.92. National Health Investors has a twelve month low of $50.57 and a twelve month high of $86.13. The stock has a 50 day moving average of $80.35 and a two-hundred day moving average of $73.74. The stock has a market cap of $3.65 billion, a P/E ratio of 27.58, a P/E/G ratio of 5.46 and a beta of 1.05.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 4.49%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio is presently 123.71%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Covestor Ltd grew its holdings in National Health Investors by 2,700.0% in the third quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 405 shares during the last quarter. International Assets Investment Management LLC acquired a new stake in National Health Investors in the second quarter valued at $36,000. Assetmark Inc. grew its holdings in National Health Investors by 27.8% in the third quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust’s stock valued at $54,000 after purchasing an additional 141 shares during the last quarter. Blue Trust Inc. grew its holdings in National Health Investors by 2,651.9% in the second quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 716 shares during the last quarter. Finally, Harbor Capital Advisors Inc. acquired a new stake in National Health Investors in the third quarter valued at $70,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.